Connect your AI

Hims & Hers Health HIMS Debt Securities, Available-for-sale, Amortized Cost, Noncurrent

Debt Securities, Available-for-sale, Amortized Cost, Noncurrent at other companies

Wells Fargo & CompanyWFC

$156.64B+6.0%

Stifel FinancialSF

$25.99M-74.8%

PaychexPAYX

$0-100%

BK

BKBK

$107.65B+9.8%

Wells Fargo & CompanyWFC

$10.14B-21.5%

Wells Fargo & CompanyWFC

$56.78B+183%

Other financials

Income statement

Revenue$608.1M+3.8%

Gross profit$396.8M-7.9%

Operating income-$78.3M-235%

Net income-$92.1M-286%

EPS (diluted)-$0.40-300%

Balance sheet

Cash & equivalents$222.3M-19.2%

Total debt$157.9M+149%

Total equity$446.2M-18.8%

Total assets$2.3B+154%

Cash flow

Operating cash flow$89.4M-18.1%

CapEx$8.8M-19.9%

Free cash flow$80.5M-17.9%

Valuation

Market cap$8.21B-27.9%

Enterprise value$8.15B-26.5%

P/S3.5×-2.9×

Profitability

Gross margin71.7%-5.3pp

Operating margin-1.3%-7.5pp

Net margin-0.6%-9.8pp

FCF margin11.9%-5.8pp

Returns & leverage

Return on equity-2.7%-39.4pp

Debt / equity0.4×+0.2×

Current ratio1.7×+0.1×

Where this comes from

Reported directly by Hims & Hers Health in its filing.

Tagged under the XBRL concept us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent.

The official record: Hims & Hers Health’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Hims & Hers Health's debt securities, available-for-sale, amortized cost, noncurrent.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Hims & Hers Health's debt securities, available-for-sale, amortized cost, noncurrent?: Hims & Hers Health (HIMS) reported debt securities, available-for-sale, amortized cost, noncurrent of $350.32M in Q4 2025.